QUICK LINKS
GTAM2 Marker Antibody (B43.2) is a mouse monoclonal IgG1 antibody that detects GTAM2 protein of human origin by western blotting (WB), immunofluorescence (IF), and immunohistochemistry with paraffin-embedded sections (IHCP). Anti-GTAM2 antibody (B43.2) is available in a non-conjugated form, providing flexibility for various experimental needs. GTAM2, or gastrointestinal tumor associated marker 2, plays a crucial role in identifying gastric carcinoma, a cancer that can arise in any part of the stomach and metastasize to other organs, including the esophagus and small intestine. GTAM2 monoclonal antibody (B43.2) detects expression in the luminal and apical cytoplasm of pancreatic cancer cells, as well as in lung, colon, and gastric carcinomas, making GTAM2 a valuable marker for malignancy. GTAM2′s presence in tumor tissues helps distinguish between benign and malignant conditions, essential for early diagnosis and effective treatment strategies. GTAM2′s unique expression profile in cancerous tissues highlights potential as a target for therapeutic interventions, as GTAM2 may interact with specific proteins involved in tumor progression and metastasis, offering insights into molecular mechanisms underlying cancer development.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
GTAM2 Marker Antibody (B43.2) | sc-59193 | 500 µl supernatant | $322.00 |